← Back to Search

Interview Group for Pancreatic Cancer (PROCLAIM Trial)

N/A

Recruiting

Led By Jen J Yeh, MD

Research Sponsored by UNC Lineberger Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years or older

History of pancreatic cancer diagnosis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 month

Awards & highlights

PROCLAIM Trial Summary

This trial aims to create a mobile app specifically for Black patients with pancreatic cancer to help them learn more about clinical trials and communicate better with their healthcare team. The goal is to increase participation of Black patients

Who is the study for?

This clinical trial is specifically for Black individuals who have been diagnosed with pancreatic cancer. It aims to address the low participation of this group in clinical trials by using a mobile health application designed to encourage discussions about trials with their healthcare team.Check my eligibility

What is being tested?

The intervention being tested is a culturally tailored informational mobile app, which will be used as an educational and communication tool. The goal is to see if this app increases engagement between Black pancreatic cancer patients and their care teams regarding clinical trial opportunities.See study design

What are the potential side effects?

Since the intervention involves feedback and interviews through a mobile app, there are no direct medical side effects associated with traditional drug treatments. However, participants may experience emotional or psychological impacts from discussing sensitive health information.

PROCLAIM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have been diagnosed with pancreatic cancer.

PROCLAIM Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The clinical trial education and communication needs

PROCLAIM Trial Design

2Treatment groups

Experimental Treatment

Group I: User Testing GroupExperimental Treatment1 Intervention

Subjects with pancreatic carcinoma who joined the user testing group

Group II: Interview GroupExperimental Treatment1 Intervention

Subjects with pancreatic carcinoma who joined the interview group.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

feedback

2007

N/A

~1530

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

UNC Lineberger Comprehensive Cancer CenterLead Sponsor

351 Previous Clinical Trials

88,307 Total Patients Enrolled

Lustgarten FoundationOTHER

23 Previous Clinical Trials

5,347 Total Patients Enrolled

Jen J Yeh, MDPrincipal InvestigatorUNC Lineberger Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available openings for patients to participate in this medical study?

"The details on clinicaltrials.gov reveal that this specific medical trial is not currently in the recruitment phase. It was initially listed on February 2, 2024, and last modified on February 1, 2024. While this study is inactive regarding patient enrollment, there are a total of 717 other trials actively seeking participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Promoting CT Engagement for Pancreatic Cancer With App

2024. "Promoting CT Engagement for Pancreatic Cancer With App". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06252545.

All > High Point > Greensboro